Szabó C, Wu C C, Gross S S, Thiemermann C, Vane J R
William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, UK.
Eur J Pharmacol. 1993 Nov 30;250(1):157-60. doi: 10.1016/0014-2999(93)90634-t.
We investigated the role of interleukin-1 in the induction of a Ca(2+)-independent nitric oxide (NO) synthase by bacterial endotoxin in vivo. In anaesthetized rats, pretreatment with interleukin-1 receptor antagonist (interleukin-1ra; 16 mg kg-1 i.v., followed by an infusion of 2.4 mg kg-1 h-1) ameliorated the delayed hypotension and tachycardia in response to endotoxin (2 mg kg-1 i.v.). Endotoxaemia for 3 h induced a Ca(2+)-independent NO synthase activity in the lung and reduced the contractions to noradrenaline in the thoracic aorta ex vivo. Treatment with interleukin-1ra attenuated both the induction of NO synthase in the lung (by 46 +/- 5%) and the endotoxin-induced hyporeactivity to noradrenaline in the aorta. Thus, endogenous interleukin-1 contributes to the induction of NO synthase in response to endotoxin in vivo.
我们研究了白细胞介素-1在体内细菌内毒素诱导的钙非依赖性一氧化氮(NO)合酶过程中的作用。在麻醉大鼠中,用白细胞介素-1受体拮抗剂(白细胞介素-1ra;静脉注射16mg/kg,随后以2.4mg/kg·h-1的速度输注)预处理可改善对内毒素(静脉注射2mg/kg)的延迟性低血压和心动过速。3小时的内毒素血症在肺中诱导出钙非依赖性NO合酶活性,并降低了离体胸主动脉对去甲肾上腺素的收缩反应。用白细胞介素-1ra治疗可减弱肺中NO合酶的诱导(降低46±5%)以及内毒素诱导的主动脉对去甲肾上腺素的反应性降低。因此,内源性白细胞介素-1在体内对响应内毒素诱导NO合酶起作用。